Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-21T14:46:31.123Z Has data issue: false hasContentIssue false
  • English
  • Français

HEALTH TECHNOLOGY ASSESSMENT IN EUROPE

Improving Clarity and Performance

Published online by Cambridge University Press:  01 April 2000

Richard Cookson  and
Alan Maynard
Richard Cookson
Affiliation:
London School of Economics
Alan Maynard
Affiliation:
University of York
Get access Rights & Permissions [Opens in a new window]

Abstract

This paper discusses the challenges facing health technology assessment (HTA) in Europe, based on an explicit analysis of the characteristics of an “optimal” HTA system. It has three objectives: a) to elaborate an explicit system of policy goals and the characteristics of an optimal HTA system that facilitates the achievement of these goals; b) to identify the general institutional incentive barriers (government and market failures) that prevent the attainment of an optimal HTA system in Europe; and c) to argue that evaluation of the implications of health technologies for equity and inequality in health is an essential part of this optimal system and a considerable challenge for HTA decision makers, especially as national governments realign policy toward equity goals.

Keywords

Technology assessmentbiomedicalEvidence-based medicineEvaluation researchHealthcare qualityAccess and evaluation
Type
Research Article
Information
International Journal of Technology Assessment in Health Care , Volume 16 , Issue 2 , April 2000 , pp. 639 - 650
Copyright
© 2000 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)